Antibody Characterization  
Development of ELISA assay
We offer ELISA assay development for diagnostics applications and in-process or immuno-monitoring controls. Used as a research tool, ELISA assays allow to assess the specificity and the affinity of the antibodies developed.

Development of BIACORE assay
We propose integrated BIACORE services including development of methods, samples testing and analysis of results. We routinely use BIACORE technology to evaluate antigen-antibody interactions and perform Kd determination for selection of antibody lead candidates.

Development of seroneutralizing test
The platform also proposes to develop cell based assays aiming at identifying the neutralizing potential of the antibodies developed. PX’Therapeutics has access to P3/P4 laboratories to deal with projects involving dangerous or lethal pathogens.